NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bristol-Myers Squibb Company (NYSE: BMY)

 
BMY Technical Analysis
2
As on 31st Oct 2017 BMY Share Price closed @ 61.66 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 56.80 & Sell for SHORT-TERM with Stoploss of 61.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BMY Share Price

Open 60.94 Change Price %
High 61.90 1 Day 0.82 1.35
Low 60.68 1 Week 0.00 0.00
Close 61.66 1 Month -3.63 -5.56
Volume 8233974 1 Year 5.29 9.38
52 Week High 66.10 | 52 Week Low 46.01
 
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
EMC 29.05 0.97%
GE 20.16 -1.22%
AKS 4.59 -21.54%
PCS 11.84 -0.92%
AMD 10.98 0.83%
WSH 47.18 -2.86%
JNS 14.17 -0.56%
XLS 24.66 -0.64%
SWY 35.10 -0.11%
 
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
TREX 109.45 25.65%
HZO 18.55 22.04%
SSD 55.74 14.62%
TBI 27.10 14.11%
SSTK 38.99 13.84%
KAI 113.60 13.09%
 
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
 
 
BMY
Daily Charts
BMY
Intraday Charts
Whats New @
Bazaartrend
BMY
Free Analysis
 
BMY Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE62.79
RESISTANCE62.32
SUPPORT61.00
SUPPORT60.53
SUPPORT0.00
SUPPORT0.00
 
BMY Target for Month October
4th UP TARGET73.82
3rd UP TARGET69.92
2nd UP TARGET67.51
1st UP TARGET65.1
1st DOWN TARGET58.22
2nd DOWN TARGET55.81
3rd DOWN TARGET53.4
4th DOWN TARGET49.5
 
BMY Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
BMY Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
BMY Other Details
Segment EQ
Market Capital 54918418432.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.bms.com
 
BMY Address
BMY
345 Park Avenue
New York, NY 10154
United States
Phone: 212-546-4000
Fax: 212-546-4020
 
BMY Latest News
 
Your Comments and Response on Bristol-Myers Squibb Company
 
BMY Business Profile
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecule products, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; metabolics; immunoscience; and cardiovascular. The company’s principal products are virology products comprising Baraclude, Reyataz, and Sustiva; oncology products, including Erbitux, Sprycel, and Yervoy; neuroscience products, such as Abilify; metabolics consisting of Bydureon, Byetta, Forxiga, and Onglyza/Kombiglyze; immunoscience products, including Nulojix and Orencia; and cardiovascular products, such as Avapro/Avalide, Eliquis, and Plavix. It has various products under Phase III clinical trials for the treatment of hepatitis C virus infection, including Asunaprevir; Daclatasvir; BMS-791325; and Peginterferon lambda. The company also has various products under Phase III clinical trials for treatment of cancer comprising Elotuzumab and Nivolumab. In addition, it develops Baraclude and Reyataz for pediatric extensions; Erbitux for esophageal cancer; Yervoy for melanoma, prostate cancer, and non-small-cell and small cell lung cancer; Orencia for lupus nephritis and psoriatic arthritis; and Eliquis for venous thromboembolic treatment and prevention. The company sells its products to wholesalers, and directly to distributors, retailers, hospitals, clinics, government agencies, and pharmacies. It has strategic alliances with various third parties. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service